Literature DB >> 18652941

Day-night variation of acute myocardial infarction in obstructive sleep apnea.

Fatima H Sert Kuniyoshi1, Arturo Garcia-Touchard, Apoor S Gami, Abel Romero-Corral, Christelle van der Walt, Snigdha Pusalavidyasagar, Tomas Kara, Sean M Caples, Gregg S Pressman, Elisardo C Vasquez, Francisco Lopez-Jimenez, Virend K Somers.   

Abstract

OBJECTIVES: This study sought to evaluate the day-night variation of acute myocardial infarction (MI) in patients with obstructive sleep apnea (OSA).
BACKGROUND: Obstructive sleep apnea has a high prevalence and is characterized by acute nocturnal hemodynamic and neurohormonal abnormalities that may increase the risk of MI during the night.
METHODS: We prospectively studied 92 patients with MI for which the time of onset of chest pain was clearly identified. The presence of OSA was determined by overnight polysomnography.
RESULTS: For patients with and without OSA, we compared the frequency of MI during different intervals of the day based on the onset time of chest pain. The groups had similar prevalence of comorbidities. Myocardial infarction occurred between 12 am and 6 am in 32% of OSA patients and 7% of non-OSA patients (p = 0.01). The odds of having OSA in those patients whose MI occurred between 12 am and 6 am was 6-fold higher than in the remaining 18 h of the day (95% confidence interval: 1.3 to 27.3, p = 0.01). Of all patients having an MI between 12 am and 6 am, 91% had OSA.
CONCLUSIONS: The diurnal variation in the onset of MI in OSA patients is strikingly different from the diurnal variation in non-OSA patients. Patients with nocturnal onset of MI have a high likelihood of having OSA. These findings suggest that OSA may be a trigger for MI. Patients having nocturnal onset of MI should be evaluated for OSA, and future research should address the effects of OSA therapy for prevention of nocturnal cardiac events.

Entities:  

Mesh:

Year:  2008        PMID: 18652941      PMCID: PMC2598735          DOI: 10.1016/j.jacc.2008.04.027

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea.

Authors:  K Narkiewicz; P J van de Borne; C A Pesek; M E Dyken; N Montano; V K Somers
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

2.  Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease.

Authors:  H Schäfer; U Koehler; T Ploch; J H Peter
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

3.  Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death.

Authors:  M C Cohen; K M Rohtla; C E Lavery; J E Muller; M A Mittleman
Journal:  Am J Cardiol       Date:  1997-06-01       Impact factor: 2.778

4.  Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms.

Authors:  Alberto Alonso-Fernández; Francisco García-Río; Miguel A Racionero; José M Pino; Fernando Ortuño; Isabel Martínez; José Villamor
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

5.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

6.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Day-night pattern of sudden death in obstructive sleep apnea.

Authors:  Apoor S Gami; Daniel E Howard; Eric J Olson; Virend K Somers
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

8.  Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.

Authors:  K Chin; M Ohi; H Kita; T Noguchi; N Otsuka; T Tsuboi; M Mishima; K Kuno
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

9.  Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.

Authors:  C Rångemark; J A Hedner; J T Carlson; G Gleerup; K Winther
Journal:  Sleep       Date:  1995-04       Impact factor: 5.849

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  79 in total

1.  Can obstructive sleep apnea be a cause of in-stent thrombosis?

Authors:  Anna Hrynkiewicz-Szymanska; Filip M Szymanski; Krzysztof J Filipiak; Marcin Grabowski; Alicja Dąbrowska-Kugacka; Grzegorz Karpinski; Grzegorz Opolski
Journal:  Sleep Breath       Date:  2010-05-23       Impact factor: 2.816

2.  Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.

Authors:  Carolina C Gonzaga; Krishna K Gaddam; Mustafa I Ahmed; Eduardo Pimenta; S Justin Thomas; Susan M Harding; Suzanne Oparil; Stacey S Cofield; David A Calhoun
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

3.  Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic.

Authors:  Navneet Sharma; Justin Lee; Irini Youssef; Moro O Salifu; Samy I McFarlane
Journal:  J Sleep Disord Ther       Date:  2017-03-10

4.  Day/Night rhythm of hemostatic factors in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; José S Loredo; Joel E Dimsdale
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

5.  Obstructive sleep apnoea increases the incidence of morning peak of onset in acute myocardial infarction.

Authors:  Hiroshi Nakashima; Tomoko Henmi; Kazutoshi Minami; Yuzou Uchida; Yoshinori Shiraishi; Tatsuya Nunohiro; Koji Maemura
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

6.  Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; Tanya Wolfson; Anthony C Gamst; José S Loredo; Joel E Dimsdale
Journal:  Sleep Med       Date:  2012-10-01       Impact factor: 3.492

7.  Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome.

Authors:  Jacek Wolf; Jacek Drozdowski; Krzysztof Czechowicz; Paweł J Winklewski; Ewa Jassem; Tomas Kara; Virend K Somers; Krzysztof Narkiewicz
Journal:  Int J Cardiol       Date:  2015-08-21       Impact factor: 4.164

8.  Obstructive sleep apnea: no independent association to troponins.

Authors:  Trygve Sørdahl Hall; Tobias Herrscher; Petr Jarolim; Morten W Fagerland; Torstein Jensen; Jonas Hallén; Stefan Agewall; Dan Atar
Journal:  Sleep Breath       Date:  2013-09-17       Impact factor: 2.816

Review 9.  Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis.

Authors:  Vanita Mehta; Tajender S Vasu; Barbara Phillips; Frances Chung
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

10.  Association between QRS duration and obstructive sleep apnea.

Authors:  Shuchita Gupta; Beatriz Cepeda-Valery; Abel Romero-Corral; Abu Shamsuzzaman; Virend K Somers; Gregg S Pressman
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.